Application of a PK-PD Modeling and Simulation-Based Strategy for Clinical Translation of Antibody-Drug Conjugates: a Case Study with Trastuzumab Emtansine (T-DM1).
about
Measurement and Mathematical Characterization of Cell-Level Pharmacokinetics of Antibody-Drug Conjugates: A Case Study with Trastuzumab-vc-MMAE.Antibody-Drug Conjugates: Pharmacokinetic/Pharmacodynamic Modeling, Preclinical Characterization, Clinical Studies, and Lessons Learned.Pharmacokinetic Considerations for Antibody-Drug Conjugates against Cancer.Gemcitabine-camptothecin conjugates: a hybrid prodrug for controlled drug release and synergistic therapeutics.
P2860
Application of a PK-PD Modeling and Simulation-Based Strategy for Clinical Translation of Antibody-Drug Conjugates: a Case Study with Trastuzumab Emtansine (T-DM1).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Application of a PK-PD Modelin ...... Trastuzumab Emtansine (T-DM1).
@en
type
label
Application of a PK-PD Modelin ...... Trastuzumab Emtansine (T-DM1).
@en
prefLabel
Application of a PK-PD Modelin ...... Trastuzumab Emtansine (T-DM1).
@en
P2860
P1433
P1476
Application of a PK-PD Modelin ...... Trastuzumab Emtansine (T-DM1).
@en
P2093
Aman P Singh
Dhaval K Shah
P2860
P2888
P304
P356
10.1208/S12248-017-0071-Y
P407
P577
2017-04-03T00:00:00Z
P6179
1084510989